150 related articles for article (PubMed ID: 32243355)
1. Neuroprotective effects of peroxisome proliferator-activated receptor γ agonist through activation of Akt and signal transducers and activators of transcription 3 in transient forebrain ischemia.
Sui X; Yoshioka H; Wakai T; Fukumoto Y; Kinouchi H
Neuroreport; 2020 Apr; 31(6):484-489. PubMed ID: 32243355
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective and antioxidative effects of pioglitazone in brain tissue adjacent to the ischemic core are mediated by PI3K/Akt and Nrf2/ARE pathways.
Zhao Y; Lützen U; Gohlke P; Jiang P; Herdegen T; Culman J
J Mol Med (Berl); 2021 Aug; 99(8):1073-1083. PubMed ID: 33864097
[TBL] [Abstract][Full Text] [Related]
3. Activation of the Akt/GSK3beta signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats.
Endo H; Nito C; Kamada H; Nishi T; Chan PH
J Cereb Blood Flow Metab; 2006 Dec; 26(12):1479-89. PubMed ID: 16538228
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
[TBL] [Abstract][Full Text] [Related]
5. Activation of signal transducer and activator of transcription-3 by a peroxisome proliferator-activated receptor gamma agonist contributes to neuroprotection in the peri-infarct region after ischemia in oophorectomized rats.
Kinouchi T; Kitazato KT; Shimada K; Yagi K; Tada Y; Matsushita N; Sumiyoshi M; Satomi J; Kageji T; Nagahiro S
Stroke; 2012 Feb; 43(2):478-83. PubMed ID: 22076002
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
[TBL] [Abstract][Full Text] [Related]
7. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
[TBL] [Abstract][Full Text] [Related]
8. Activation of cerebral peroxisome proliferator-activated receptors γ (PPARγ) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat.
Zuhayra M; Zhao Y; von Forstner C; Henze E; Gohlke P; Culman J; Lützen U
Neuropathol Appl Neurobiol; 2011 Dec; 37(7):738-52. PubMed ID: 21366664
[TBL] [Abstract][Full Text] [Related]
9. Post-ischemic administration of pravastatin reduces neuronal injury by inhibiting Bax protein expression after transient forebrain ischemia in rats.
Jung YS; Oh AY; Park HP; Hwang JW; Lim YJ; Jeon YT
Neurosci Lett; 2015 May; 594():87-92. PubMed ID: 25800111
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
11. Proteomics-Guided Study on Buyang Huanwu Decoction for Its Neuroprotective and Neurogenic Mechanisms for Transient Ischemic Stroke: Involvements of EGFR/PI3K/Akt/Bad/14-3-3 and Jak2/Stat3/Cyclin D1 Signaling Cascades.
Chen X; Chen H; He Y; Fu S; Liu H; Wang Q; Shen J
Mol Neurobiol; 2020 Oct; 57(10):4305-4321. PubMed ID: 32700252
[TBL] [Abstract][Full Text] [Related]
12. PPARgamma agonist pioglitazone reduces [corrected] neuronal cell damage after transient global cerebral ischemia through matrix metalloproteinase inhibition.
Lee KJ; Jang YH; Lee H; Yoo HS; Lee SR
Eur J Neurosci; 2008 Jan; 27(2):334-42. PubMed ID: 18215232
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARγ-independent pathway.
Tsubaki M; Takeda T; Tomonari Y; Kawashima K; Itoh T; Imano M; Satou T; Nishida S
J Cell Physiol; 2018 Apr; 233(4):3638-3647. PubMed ID: 29030979
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways.
Simão F; Matté A; Pagnussat AS; Netto CA; Salbego CG
Eur J Neurosci; 2012 Oct; 36(7):2899-905. PubMed ID: 22817531
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats.
Park SW; Yi JH; Miranpuri G; Satriotomo I; Bowen K; Resnick DK; Vemuganti R
J Pharmacol Exp Ther; 2007 Mar; 320(3):1002-12. PubMed ID: 17167171
[TBL] [Abstract][Full Text] [Related]
16. Delta opioid peptide [D-Ala2, D-Leu5] enkephalin (DADLE) triggers postconditioning against transient forebrain ischemia.
Wang S; Duan Y; Su D; Li W; Tan J; Yang D; Wang W; Zhao Z; Wang X
Eur J Pharmacol; 2011 May; 658(2-3):140-4. PubMed ID: 21349267
[TBL] [Abstract][Full Text] [Related]
17. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
Cao Z; Ye P; Long C; Chen K; Li X; Wang H
Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma dependent pathway reduces the phosphorylation of dynamin-related protein 1 and ameliorates hippocampal injury induced by global ischemia in rats.
Chuang YC; Lin TK; Yang DI; Yang JL; Liou CW; Chen SD
J Biomed Sci; 2016 May; 23(1):44. PubMed ID: 27175924
[TBL] [Abstract][Full Text] [Related]
19. Effects of PPARγ agonist pioglitazone on cardiac fibrosis in diabetic mice by regulating PTEN/AKT/FAK pathway.
Zhang XD; Sun GX; Guo JJ; Hu CC; Sun RC; Yu HC
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):812-819. PubMed ID: 33577036
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression.
Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
Anticancer Agents Med Chem; 2021; 21(1):108-119. PubMed ID: 32807067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
